Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 147.41M P/E - EPS this Y - Ern Qtrly Grth -
Income -27.75M Forward P/E -6.76 EPS next Y -10.00% 50D Avg Chg -4.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg 32.00%
Dividend N/A Price/Book 5.72 EPS next 5Y - 52W High Chg -32.00%
Recommedations 2.00 Quick Ratio 8.24 Shares Outstanding 75.42M 52W Low Chg 111.00%
Insider Own 6.16% ROA -55.47% Shares Float 66.96M Beta 1.46
Inst Own 6.88% ROE -102.66% Shares Shorted/Prior 0.93M/1.04M Price 2.30
Gross Margin - Profit Margin - Avg. Volume 1,023,745 Target Price 4.80
Oper. Margin - Earnings Date May 3 Volume 853,043 Change -2.95%
About Oncolytics Biotech Inc.

Oncolytics Biotech Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. The company is developing pelareorep, an intravenously delivered immunotherapeutic agent, which is in phase 3 clinical trial for the treatment of hormone receptor-positive / human epidermal growth factor 2-negative metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma. It has a co-development agreement with Merck KGaA and Pfizer Inc. to co-develop pelareorep, as well as with Roche Holding AG. The company was incorporated in 1998 and is headquartered in Calgary, Canada.

Oncolytics Biotech Inc. News
04/11/24 Oncolytics Biotech® Advances Toward Registration-Enabling Trial for Pelareorep in Breast Cancer with Submission of Type C Meeting Request to FDA
04/02/24 Oncolytics Biotech® to Participate in a Panel Presentation at Canaccord Genuity's Horizons in Oncology Virtual Conference
03/10/24 Oncolytics Biotech Inc. (NASDAQ:ONCY) Q4 2023 Earnings Call Transcript
03/07/24 Oncolytics Biotech® Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights
03/06/24 Biotech/Oncology Stocks Targeting the Pancreatic Cancer Market - A Race Worth Winning
03/05/24 Oncolytics Biotech® Files Amendment to Initiate New Pancreatic Cancer GOBLET Cohort Supported by PanCAN
03/04/24 Oncolytics Biotech® to Host Conference Call to Discuss Fourth Quarter and Full Year Financial Results and Recent Operational Highlights
02/28/24 Oncolytics Biotech® Announces Presentation at the Cancer Advocacy Group of Louisiana's 3rd Annual NeauxCancer Conference
02/15/24 Here's Why We're Watching Oncolytics Biotech's (TSE:ONC) Cash Burn Situation
02/15/24 Cancer Immunotherapy Stocks - Tapping into Immune Systems for Next Generation Treatments
02/14/24 Oncolytics Biotech® Initiates Enrollment Expansion of GOBLET Anal Cancer Cohort
01/09/24 Oncolytics Biotech® Appoints Patricia S. Andrews to its Board of Directors
01/04/24 Oncolytics Biotech® Recaps 2023 Accomplishments, Provides Outlook for 2024
12/07/23 Oncolytics Biotech® and SOLTI Present Positive Translational Data at SABCS
11/09/23 Oncolytics Announces the Anal Cancer Cohort of the GOBLET Phase 1/2 Study of Pelareorep and Atezolizumab Has Met the Success Criteria for Efficacy
11/09/23 Oncolytics Provides Update on Pancreatic Cancer Program for Pelareorep
11/05/23 Oncolytics Biotech Inc. (NASDAQ:ONCY) Q3 2023 Earnings Call Transcript
11/03/23 Oncolytics Biotech® and SOLTI Present Further Positive Pelareorep Translational Data at SITC
11/03/23 Oncolytics Biotech® Reports Third Quarter 2023 Financial Results and Operational Highlights
10/23/23 Oncolytics Presents Positive Updated Pancreatic Cancer Data from GOBLET Phase 1/2 Study at ESMO
ONCY Chatroom

User Image Dude1234 Posted - 22 hours ago

$ONCY On LinkedIn, Interesting.

User Image DarkSilver Posted - 1 day ago

$ONCY

User Image ANNACOTSTEEL Posted - 1 day ago

$ONCY Been out of this name. Still don't believe in it and Mr Coffey. Only thing they've proven is the ability to issue shares and dilute shareholders. However, stock's back to its floor and weekly oversold is crossing up so maybe there's a trade. Wondering if there is any spin on it coming soon to get some people excited and bid this thing up for a while? Thanks

User Image saxy4u Posted - 1 day ago

$ONCY

User Image aaron03 Posted - 1 day ago

$ONCY It looks like Canadafan14 (aka Brad) and Azzak34 have left this message board to infiltrate the Stockhouse message board and spew their opinions on that site. I guess they couldn't handle the negativity or the criticism that was thrown their way over here.

User Image Humblebutgr8 Posted - 1 day ago

$ONCY This is your chance to VOTE and let management know if you approve of the progress to commercialization of pelo and the communication you have received as a shareholder in this company. Please vote!

User Image De_man Posted - 2 days ago

$ONCY Hello all and I said I would get back to everyone if I heard something from ONCY in regards to the voting for, against or withheld and the change in legislation. The short answer out of the email is as follows. "Regarding your query, it does not apply to Oncolytics." So my guess out of this is that they are not governed by the cbca but that was not addressed.

User Image aaron03 Posted - 2 days ago

$ONCY See post below from @ddtrades2000 I received my proxy vote today in regards to the AGM. I voted against retaining the entire management team. I have no issues with pelareorep. I have a major problem with the delays and lack of transparency from the entire management team. They have failed shareholders (particularly the long-term shareholders)

User Image ddtrades2000 Posted - 2 days ago

$ONCY something to think about when voting : Return YTD : -21.48% Return 1 Yr : -7.83% Return 3 Yr : - 65.47% Management does not care about providing a return to shareholders they earn excess of 1m / year with these results, why should they?

User Image saxy4u Posted - 3 days ago

$ONCY their back!!!! This thing is going under $1 this month before the AGM. Short attackers are here. GL all!

User Image ThomasIchim Posted - 3 days ago

Do you remember when I wrote some positive words on $ONCY ? I love this #immunotherapy approach to #cancer

User Image DarkSilver Posted - 3 days ago

$ONCY So what's the matter of the day?

User Image aaron03 Posted - 3 days ago

$ONCY With the AGM coming up, is there anyone who would vote for keeping the board members? Personally, I'm leaning against retaining management

User Image Dude1234 Posted - 3 days ago

$ONCY Guess there's no public link for todays Canaccord Genuity Conference.

User Image saxy4u Posted - 5 days ago

$ONCY

User Image saxy4u Posted - 5 days ago

$ONCY Irene estimated to finish June 2024 and final results expected Bravelet July 24 both updated April 2/24. FYI

User Image FoxM07 Posted - 5 days ago

@m00nsh0t @JohnnyC63 @De_man why are we stressing about this? The brain trust on SH says we've already won, and SP doesn't matter!! Noteable is on record saying AA & B/O will both come by the summer!! He/she also wrote that we'll be surprised with who acquires $ONCY!! Relax!!!!!;)

User Image De_man Posted - 6 days ago

$ONCY AGM It would appear that we only get a virtual meeting as I am sure it would be too difficult for management to give shareholders a chance to ask any questions. NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS NOTICE IS HEREBY GIVEN that an annual meeting (the “Meeting”) of the holders (“Shareholders”) of common shares of Oncolytics Biotech Inc. (the “Corporation”) will be held as follows: When: Wednesday, May 15, 2024 at 4:00 p.m. (Toronto time) Where: Virtual-only meeting via live audio webcast online at https://virtual-meetings.tsxtrust.com/1612 Password: onc2024 (case sensitive)

User Image Dude1234 Posted - 6 days ago

$ONCY Just doing a search while getting ready for work. It's a pay medical site unfortunately and it's only a part of text. Would seem to suggest they are working on a fomulation for next step in Panc. GLTA.

User Image Stocks4thought Posted - 6 days ago

$ONCY Needs a Tik Tok video Cofee in Pinto Wagons.

User Image FoxM07 Posted - 6 days ago

$ONCY "...2024 is poised to be a transformitive year for Oncolytics & our stakeholders." That's been the rallying cry since Nov.2022 with the oft mentioned "next 6 to 9 months will be the most exciting and important in our history." The market is still waiting for you to over-deliver Matty. Btw, '24 will be half over in no time...tick-toc...

User Image fessr Posted - 1 week ago

$ONCY

User Image Stocks4thought Posted - 1 week ago

$ONCY Stronger than you know- whoop ask.

User Image CaseyLe Posted - 1 week ago

$ONCY Registration Enabling Trial means any Clinical Trial that is intended to, or does, generate data sufficient to enable the Filing of a Marketing Application in any country in the Territory.

User Image JohnnyC63 Posted - 1 week ago

$ONCY

User Image Stock_Titan Posted - 1 week ago

$ONCY Oncolytics Biotech® Advances Toward Registration-Enabling Trial for Pelareorep in Breast Cancer with Submission of Type C Meeting Request to FDA https://www.stocktitan.net/news/ONCY/oncolytics-biotech-r-advances-toward-registration-enabling-trial-for-8wkcfl3iwoyf.html

User Image Stocks4thought Posted - 1 week ago

$ONCY Hotter than Mike Tyson's cosmetology course.

User Image aaron03 Posted - 1 week ago

$ONCY Unusual action in premarket today. What's the end result? Nothing. Just another red day for ONCY. AGM will be another dud this year.

User Image DarkSilver Posted - 1 week ago

$ONCY Great Start

User Image Canadafan14 Posted - 1 week ago

$ONCY was quite a bit of very early premarket activity. who knows , culd carrying on into the regurlar trading? Sometimes the premarket is an indicator, sometimes not. either way S.P. is way way under priced. Due for a run up.

Analyst Ratings
Raymond James Outperform Apr 4, 24
HC Wainwright & Co. Buy Mar 8, 24
HC Wainwright & Co. Buy Feb 14, 24
HC Wainwright & Co. Buy Jan 19, 24
HC Wainwright & Co. Buy Jan 4, 24
HC Wainwright & Co. Buy Nov 13, 23
HC Wainwright & Co. Buy Aug 16, 23
HC Wainwright & Co. Buy Jun 29, 23
Canaccord Genuity Buy Jun 23, 23